BUFFALO, N.Y., April 24, 2012 /PRNewswire-iReach/ -- Empire Genomics today announced that it has chosen Funakoshi as a distributor of its product portfolio for the Japanese market. The deal represents Empire's international expansion and importance of growth in the region.
"We are excited to have such a proven and expert partner in Funakoshi to service our Japanese customers and offer access to our broad genomic product and service portfolio," said Anthony Johnson, President and CEO of Empire Genomics. "I am confident this relationship will provide customers with the excellent support and high quality service our customers have come to expect."
"We are delighted with Empire Genomics agreement. Empire Genomics perfectly complements our portfolio range of high quality products and services. Empire Genomics portfolio provides Funakoshi Company the opportunity to meet high demands for basic bioscience research and also for the pharmaceutical research in Japan." said Dr.Ryoya Funakoshi, President & CEO of Funakoshi Company, Ltd.
Financial terms of the deal were not disclosed.
About Empire Genomics, LLC
Empire Genomics delivers the most advanced genomic tools to aid the scientific community in its research and diagnostic challenges. Through many years of experience in the area of genomics and working with diverse sample types, we are able to provide continuous innovation for research and diagnostic applications in areas of oncology, biomarkers, drug discovery, constitutional disorders, developmental disorders and autism, among many others.
About Funakoshi Co. Ltd.
Funakoshi Co., Ltd. has contributed as a leader to distribute research reagents and instruments for researchers in life science fields since its foundation. The mission of Funakoshi is offering many useful tools with leading edge technologies for Japanese researchers from all over the world to support and develop their research. For more information, visit Funakoshi's website: www.funakoshi.co.jp.Media Contact:
Sonya Stutts Empire Genomics, LLC, 716-856-3873, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
|SOURCE Empire Genomics, LLC|
Copyright©2010 PR Newswire.
All rights reserved